Paul Thornton
Pediatric Endocrinology · Fort Worth, TXNPI 1265521108
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,358 of the $52,382 with a category attached, or 61.8%. 10 manufacturers reported payments, led by Zealand Pharma A/s at 47.1% of the total. Reporting peaked in 2024 at $24,801 and has fallen 53.6% since, to $11,516 in 2025. Among pediatric endocrinology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $858.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zealand Pharma A/s$25K
- Neurocrine Biosciences, Inc.$23K
- Pfizer$4K
- EMD Serono, Inc.$683
- Novo Nordisk$267
- Tolmar Pharmaceuticals, Inc.$107
- plus $198 from 4 others
Across 301 payments — averaging $2620.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zealand Pharma A/s$373K
- Ascendis Pharma Endocrinology Inc$182K
- Pfizer$81K
- Dompe Farmaceutici S.p.a.$71K
- Novo Nordisk AS$60K
- IBSA Institut Biochimique SA$23K
What the payments were for
- Consulting fees$32,35862%
- Speaking & faculty fees$3,8507%
- Travel & lodging$14,47028%
- Food & beverage$1,6123%
- Education$920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zealand Pharma A/s | 9 | $24,692 |
| Neurocrine Biosciences, Inc. | 39 | $22,586 |
| Pfizer | 1 | $3,850 |
| EMD Serono, Inc. | 1 | $683 |
| Novo Nordisk | 4 | $267 |
| Tolmar Pharmaceuticals, Inc. | 2 | $107 |
| Tolmar, Inc. | 1 | $73 |
| Biomarin Pharmaceutical Inc. | 2 | $60 |
| Eton Pharmaceuticals, Inc. | 1 | $41 |
| Zimvie Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRENESSITY$7,991
- GENOTROPIN$3,850
How this compares
$52,382 in reported general payments places this provider in the 90th percentile of 120 pediatric endocrinology providers in Texas.
Other pediatric endocrinology in Fort Worth
- Donnie WilsonFort Worth$58K
- Joel SteelmanFort Worth$20K
- John DallasFort Worth$6K
- Luke CielonkoFort Worth$3K
- Sani RoyFort Worth$3K
- Jose Gamez-GodoyEdinburg$207K
- Virginia AraizaHouston$151K
- Daniel DesalvoHouston$133K
- Amy BurtonPlano$130K
- Susan NunezAustin$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.